Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $48.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BDRX, Q2 2026
No superinvestor reported holding BDRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Biodexa Pharmaceuticals Plc insiders from Form 4, newest first.
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Biodexa Pharmaceuticals Plc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 14,809 | $43.1K | 0.00% | −4,695−24.1% | ReducedConverted for a 1-for-5 split |
| GAMMA Investing LLC | 1,203 | $3.50K | 0.00% | −1,553−56.3% | ReducedConverted for a 1-for-5 split |
| Allied Private Wealth LLC | 489 | $1.27K | 0.00% | +489 | New |
| SBI Securities Co., Ltd. | 29 | $84 | 0.00% | −1−4.0% | ReducedConverted for a 1-for-5 split |
| UBS Group AG | 25 | $73 | 0.00% | −0−1.6% | ReducedConverted for a 1-for-5 split |
| Hilton Head Capital Partners, LLC | 6 | $17 | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Caitong International Asset Management Co., Ltd | 5 | $15 | 0.00% | +5+2,400.0% | AddedConverted for a 1-for-5 split |
| Rhumbline Advisers | 3 | $8 | 0.00% | −1−21.1% | ReducedConverted for a 1-for-5 split |
Holders of 5% or more of BDRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biodexa Pharmaceuticals Plc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 9.99%26.2K shares | 0.00 ppfrom 9.99% | Feb 14, 20235 filings | Aug 14, 2026 | SEC |
| Sabby Management, LLC | 13G | 9.90%217.6K shares | New | Jan 20, 20261 filing | Jan 20, 2026 | SEC |